Sino Biopharmaceutical Limited
1177
Performance
About Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited is a leading pharmaceutical group in China specializing in innovative research and development. The company operates across the entire pharmaceutical industry chain, including R&D platforms, intelligent production, and sales. Its product portfolio includes biological and chemical drugs targeting liver diseases, tumors, cardiovascular and cerebrovascular conditions, orthopedics, digestive, immune, and respiratory disorders.
Recent News
Phrontline Biopharma Raises $60M in Pre-A+ Financing
Pharma Pipeline Stalls for First Time in Decades: Citeline
Genentech, SanegeneBio Launch Up-to-$1.7B RNAi Collaboration
Bone Disease Readout Sinks Mereo, Ultragenyx Shares: Clinical Roundup
Kali Therapeutics Partners with Sanofi for KT501 in a ~$1.2B Deal
VantAI Gets $80M and New Name; Dynavax Discloses It Had Pre-Sanofi Suitor